Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment was more effective for scalp hair regrowth but caused more irritation.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

A goat's skin infection was cured with itraconazole and D-biotin.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Cinainu is effective and safe for treating children's alopecia areata.

Candida nail infections need lab tests for accurate diagnosis and treatment.

These new skin treatments are safer and more effective with minimal side effects.

DCP in isopropanol is better tolerated for treating alopecia areata.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

Some treatments worked for horse ringworm, but mass treatment should focus on stopping infection spread, not just hair regrowth.

Spironolactone is a safe and effective hair loss treatment, especially with minoxidil.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Abrocitinib may effectively treat Lichen Planopilaris.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Triamcinolone can regrow hair in alopecia areata, but the effect is temporary.

Nanocarriers in gel may reduce side effects of oral hair loss treatments.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.